Fast-acting MYLANTA® and Extra Strength Fast-Acting MYLANTA® are well-balanced, pleasant-tasting, antacid/anti-gas medications that provide consistent, effective relief of symptoms associated with gastric hyperacidity and excess gas. Non-constipating and very low sodium Fast-Acting MYLANTA® and Extra Strength Fast-Acting MYLANTA® contain two proven antacids, aluminum hydroxide and magnesium hydroxide, plus simethicone for gas relief.
Each 5 mL teaspoon contains:
Butylparaben, carboxymethylcellulose sodium, flavors, hydroxypropyl methylcellulose, microcrystalline cellulose, propylparaben, purified water, saccharin sodium, and sorbitol.
Each 5 mL teaspoon contains the following amount of sodium:
ACID NEUTRALIZING CAPACITY
Two teaspoonfuls have the following acid neutralizing capacity:
Fast-Acting MYLANTA® and Extra Strength Fast-Acting MYLANTA® are indicated for the relief of acid indigestion, heartburn, sour stomach, and symptoms of gas and upset stomach associated with those conditions. Fast-Acting MYLANTA® and Extra Strength Fast-Acting MYLANTA® are also indicated as antacids for the symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer, gastritis, peptic esophagitis, heartburn and hiatal hernia and as antiflatulents to alleviate the symptoms of mucus-entrapped gas, including postoperative gas pain.
Fast-Acting MYLANTA and Extra Strength Fast-Acting MYLANTA are homogenized for a smooth, creamy taste. The choice of three pleasant-tasting liquid flavors and the non-constipating formula encourage patient acceptance, thereby minimizing the skipping of prescribed doses. Fast-Acting MYLANTA and Extra Strength Fast-Acting MYLANTA are also available in tablets, and both the liquid and tablet forms are very low in sodium. Fast-Acting MYLANTA and Extra Strength Fast-Acting MYLANTA provide consistent relief in patients suffering from distress associated with hyperacidity, mucus-entrapped gas, or swallowed air.
Shake well. 2-4 teaspoonfuls between meals and at bedtime, or as directed by a physician.
Keep this and all drugs out of the reach of children. Do not take more than 24 tsps of Fast-Acting MYLANTA® or 12 tsps of Extra Strength Fast-Acting MYLANTA® in a 24-hour period or use the maximum dose of this product for more than two weeks, except under the advice and supervison of a physician. Do not use this product if you have kidney disease.
Prolonged use of aluminum-containing antacids in patients with renal failure may result in or worsen dialysis osteomalacia. Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes. Small amounts of aluminum are absorbed from the gastrointestinal tract and renal excretion of aluminum is impaired in renal failure. Aluminum is not well removed by dialysis because it is bound to albumin and transferrin, which do not cross dialysis membranes. As a result, aluminum is deposited in bone, and dialysis osteomalacia may develop when large amounts of aluminum are ingested orally by patients with impaired renal function.
Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract, thus decreasing phosphate absorption. Prolonged use of aluminum-containing antacids by normophosphatemic patients may result in hypophosphatemia if phosphate intake is not adequate. In its more severe forms, hypophosphatemia can lead to anorexia, malaise, muscle weakness, and osteomalacia.
Antacids may interact with certain prescription drugs. If you are presently taking a prescription drug, do not take this product without checking with your physician or other health professional.
Fast-Acting MYLANTA® and Extra Strength Fast-Acting MYLANTA® are available as white liquid suspensions in pleasant-tasting flavors, Original, Cherry Creme and Cool Mint Creme. Liquids are supplied in bottles of 5 oz, 12 oz, and 24 oz. Also available for hospital use in liquid unit dose bottles of 1 oz and bottles of 5 oz.
NDC 16837-610 ORIGINAL LIQUID
NDC 16837-629 COOL MINT CREME LIQUID
NDC 16837-621 CHERRY CREME LIQUID
NDC 16837-817 Lemon Twist Liquid
NDC 16837-652 ORIGINAL LIQUID
NDC 16837-624 COOL MINT CREME LIQUID
NDC 16837-622 CHERRY CREME LIQUID
NDC 16837-818 Lemon Twist Liquid
Stress-induced upper gastrointestinal hemorrhage: Extra Strength Fast-Acting MYLANTA® is indicated for the prevention of stress-induced upper gastrointestinal hemorrhage. Hyperacidic conditions: As an antacid, for the symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer and other gastrointestinal conditions where a high degree of acid neutralization is desired.
Prevention of stress-induced upper gastrointestinal hemorrhage: 1) Aspirate stomach via nasogastric tube* and record pH. 2) Instill 10 mL of Extra Strength Fast-Acting MYLANTA® followed by 30 mL of water via nasogastric tube. Clamp tube. 3) Wait one hour. Aspirate stomach and record pH. 4a) If pH equals or exceeds 4.0, apply drainage or intermittent suction for one hour, then repeat the cycle. 4b) If pH is less than 4.0, instill double (20 mL) Extra Strength Fast-Acting MYLANTA® followed by 30 mL of water. Clamp tube. 5) Wait one hour. If pH equals or exceeds 4.0, see number 7, if pH is still less than 4.0, instill double (40 mL) Extra Strength Fast-Acting MYLANTA® followed by 30 mL of water. Clamp tube. 6) Wait one hour. If pH equals or exceeds 4.0, see number 7. If pH is still less than 4.0, instill double (80 mL)** Extra Strength Fast-Acting MYLANTA® followed by 30 mL of water. 7) Drain for one hour and repeat cycle with the effective dosage of Extra Strength Fast-Acting MYLANTA®.
* If nasogastric tube is not in place, administer 20 mL of Extra Strength Fast-Acting MYLANTA® orally q2h.
** In a recent clinical study 1 20 mL of Extra Strength Fast-Acting MYLANTA®, q2h, was sufficient in more than 85 percent of the patients. No patient studied required more than 80 mL of Extra Strength Fast-Acting MYLANTA® q2h.
In hyperacid states for symptomatic relief: One or two teaspoonfuls as needed between meals and at bedtime or as directed by a physician. Higher dosage regimens may be employed under the direct supervision of a physician in the treatment of active peptic ulcer disease.
Aluminum-magnesium hydroxide containing antacids should be used with caution in patients with renal impairment.
Occasional regurgitation and mild diarrhea have been reported with the dosage recommended for the prevention of stress-induced upper gastrointestinal hemorrhage.
References: 1. Zinner MJ, Zuidema GD, Smigh PL, Mignosa M: The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obster 153:214-220, 1981. 2. Lucas CE, Sugawa C, Riddle J, et al.: Natural history and surgical dilemma of "stress" gastric bleeding. Arch Surg 102:266-273, 1971. 3. Hastings PR, Skillman JJ, Bushnell LS, Silen W: Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med 298:1042-1045, 1978. 4. Day SB, MacMillan BG, Altemeier WA: Curling 's Ulcer, An Experience of Nature. Springfield, IL, Charles C Thomas Co., 1972, p. 205. 5. Skillman JJ, Bushnell LS, Goldman H, Silen W: Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg 117:523-530, 1969. 6. Priebe HJ, Skillman J, Bushnell LS, et al. Antacid versus cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med 302:426-430, 1980. 7. Silen W: The prevention and management of stress ulcers. Hosp Pract 15:93-97, 1980. 8. Herrmann V, Kaminski DL: Evaluation of intragastric pH in acutely ill patients. Arch Surg 114:511-514, 1979. 9. Martin LF, Staloch DK, Simonowitz DA, et al.: Failure of cimetidine prophylaxis in the critically ill. Arch Surg 114:492-496, 1979. 10. Zinner MJ, Turtinen L, Gurll NJ, Reynolds DG: The effect of metiamide on gastric mucosal injury in rat restraint. Clin Res 23:484A, 1975. 11. Zinner M, Turtinen BA, Gurll NJ: The role of acid and ischemia in production of stress ulcers during canine hemorrhagic shock. Surgery 77:807-816, 1975. 12. Winans CS: Prevention and treatment of stress ulcer bleeding: Antacids or cimetidine? Drug Ther Bull (hospital) 12:37-45, 1981.